Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

[This corrects the article DOI: 10.1371/journal.pone.

Comment on "Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa".

A recent study showed how geospatial mapping can be used to improve Lesotho's HIV treatment program to achieve the 90-90-90 targets set by the United Nations but incorrectly describes "treatment as prevention" as the UN's strategy for a successful national AIDS response.

Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

[This corrects the article DOI: 10.1371/journal.pone.

What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

In 2011 a new Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and AIDS-related deaths in low and middle income countries by 2015. This framework included ambitious coverage goals for prevention and treatment services for 2015, resulting in a reduction of new HIV infections by more than half, in line with the goals of the declaration of the UN High Level Meeting in June 2011. However, the approach suggested a leveling in the number of new infections at about 1 million annually-far from the UNAIDS goal of ending AIDS by 2030.

[Decrease of HCV seroprevalence in Mexico: Results from the National Health and Nutrition Survey 2012].

Objective: To estimate seroprevalence of hepatitis C virus (HCV) among 15-49 years old Mexicans living in households and to describe the profile of seroreactive individuals.

Materials And Methods: Cross-sectional study implemented in 2012 using a national probabilistic sample with behavioral data from face-to-face interviews at households and HCV antibodies screening using capillary blood from same individuals.

Results: HCV seroprevalence in Mexico was estimated at 0.

[HIV seroprevalence among Mexicans age 15 to 49: results from the National Health & Nutrition Survey 2012].

Objective: To estimate the HIV seroprevalence among Mexicans aged 15 to 49 years old and living in households, and to describe the profile of serorreactive individuals.

Materials And Methods: Cross-sectional study with a national probabilistic sample of individuals aged 15 to 49 years with behavioral data from direct interview (face-to-face) at households and HIV screening using capillary blood collected from the same individuals.

Results: A seroprevalence of 0.

Are we spending too much on HIV?

Billions of pounds are being spent on the fight against AIDS in developing countries. believes that much of the money could be better used elsewhere, whereas argue that current spending is not enough